Sitagliptin for Prevention of Acute Graft Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation
Clinical trial NCT02683525 · COMPLETED
Trial details
- NCT number
- NCT02683525
- Sponsor
- Sherif S. Farag
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-02-03
- Primary completion
- 2019-02-13
- Enrollment
- 37
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.